- NRx Pharmaceuticals Inc (NASDAQ:NRXP) shares are down Friday as it evaluated whether there are any conditions or events that could raise substantial doubt about its ability to continue as a going concern within one year beyond the date of filing its annual report.
- The company has generated no revenues, has incurred operating losses since inception, and expects to continue to incur significant operating losses for the foreseeable future and may never become profitable.
- Related: Monitoring Board Recommends NRx Pharma’s Suicidal Bipolar Depression Study To Continue Enrollment.
- The company depends on obtaining the necessary equity and/or debt financing to continue operations and cannot make any assurances that sales of its lead product, NRX-101, will commence in the near term, or that additional financing will be available to it.
- This could negatively impact the company’s business and operations and could also reduce the company’s operations.
- As of December 31, 2022, the cash balance was $20.1 million.
- Price Action: NRXP shares are down 10.58% at $0.6691 on the last check Friday.
‘Troll Post Of The Day:’ Dogecoin Lover Elon Musk Reacts To Post Mocking Cypto As ‘F***ing Lame’
X owner Elon Musk on Thursday responded to a criticism about cryptocurrencies.
What Happened: Musk was responding to a tweet by an X user that said, "Crypto is so f***ing lame it's insane."
Musk called the tweet a “Troll post of the day!”
